These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21641061)

  • 21. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
    Mehran R; Aymong ED; Nikolsky E; Lasic Z; Iakovou I; Fahy M; Mintz GS; Lansky AJ; Moses JW; Stone GW; Leon MB; Dangas G
    J Am Coll Cardiol; 2004 Oct; 44(7):1393-9. PubMed ID: 15464318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
    Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
    J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
    Gao YM; Li D; Cheng H; Chen YP
    Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the blood urea nitrogen-to-left ventricular ejection fraction ratio with contrast-induced nephropathy in patients with acute coronary syndrome who underwent percutaneous coronary intervention.
    Kiris T; Avci E; Celik A
    Int Urol Nephrol; 2019 Mar; 51(3):475-481. PubMed ID: 30604231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between contrast dose and renal complications post PCI across the continuum of procedural estimated risk.
    Kooiman J; Seth M; Share D; Dixon S; Gurm HS
    PLoS One; 2014; 9(3):e90233. PubMed ID: 24625555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous coronary intervention causes increase of serum cystatin C concentration even in the patients with a low risk of contrast-induced nephropathy.
    Tanaga K; Tarao K; Nakamura Y; Inoue T; Jo K; Ishikawa T; Miyazaki A
    Cardiovasc Interv Ther; 2012 Sep; 27(3):168-73. PubMed ID: 22692693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T; Tanık VO; Aruğaslan E; Karabağ Y; Çağdaş M; Rencüzoğulları İ; Keskin M
    Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention].
    Fu NK; Yang SC; Chen YL; Xu J; Li Q; Li XM; Liu YY; Liu XG; Cong HL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):551-4. PubMed ID: 22490160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
    Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
    Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
    Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW
    Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Mehran R; Owen R; Chiarito M; Baber U; Sartori S; Cao D; Nicolas J; Pivato CA; Nardin M; Krishnan P; Kini A; Sharma S; Pocock S; Dangas G
    Lancet; 2021 Nov; 398(10315):1974-1983. PubMed ID: 34793743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An echocardiographic predictor of contrast-induced nephropathy following percutaneous coronary intervention in acute coronary syndrome: aortic valve sclerosis.
    Durak H; Erdoğan T; Çetin M; Kocaman SA; Durakoğlugil ME; Duman H; Ergül E; Şatıroğlu Ö
    Scand Cardiovasc J; 2020 Aug; 54(4):227-231. PubMed ID: 32075450
    [No Abstract]   [Full Text] [Related]  

  • 34. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
    Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
    Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Karabay CY; Şengül C; Tanalp AC; Fotbolcu H; Özveren O; Bitigen A; Pala S; Kırma C
    Int J Cardiol; 2013 Oct; 168(4):3480-5. PubMed ID: 23688433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy after percutaneous coronary intervention in acute myocardial infarction.
    Zbierska-Rubinkiewicz K; Trębacz O; Tomala M; Rubinkiewicz M; Chrzan I; Gackowski A
    Folia Med Cracov; 2017; 57(3):87-99. PubMed ID: 29263458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH; Liu Y; Zhou YL; He PC; Yu DQ; Li LW; Xie NJ; Guo W; Tan N; Chen JY
    Am J Cardiol; 2016 Jun; 117(12):1896-903. PubMed ID: 27161818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization.
    Capodanno D; Ministeri M; Dipasqua F; Dalessandro V; Cumbo S; Gargiulo G; Tamburino C
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):524-9. PubMed ID: 25304032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.